Medicure
Albert D. Friesen is the founder and CEO of Medicure Inc, a specialty pharmaceutical company focused on therapeutics for the U.S. hospital market. Albert D. also served as CEO of GVI, an enhanced life science incubator. Additionally, they held the position of Principal at GVI Clinical Development Solutions, providing strategic consulting and clinical development support to various companies. Friesen was the CEO of CentreStone Ventures and the founder and Business Development leader at CanAm Bioresearch Inc., a pharmaceutical contract research organization. Prior to these roles, they served as the President of Winnipeg Rh Institute Inc. from 1971 to 1991.
Albert D. Friesen obtained their Ph.D. in Protein Chemistry from the University of Manitoba, where they attended from 1965 to 1981.
This person is not in any teams
Medicure
Medicure Inc (TSXV:MPH) is a pharmaceutical company focused on the development and commercialization of cardiovascular medicines for the U.S. market. Our vision is to become a leading pharmaceutical company within the U.S., offering a growing portfolio of products that improve patients' lives. We take pride in providing safe, efficacious, and cost-effective cardiovascular medicines that benefit both patients and healthcare providers. Currently, we focus on the marketing & distribution of: 1. AGGRASTAT® (tirofiban hydrochloride) injections, a hospital-based product used in the cardiac catheterization lab. AGGRASTAT is the #1 used medication of its class in the U.S. 2. ZYPITAMAG® (pitavastatin) tablets, the latest statin medication approved by the FDA in 2017. In 2020, we acquired Marley Drug, a local pharmacy in North Carolina. Our acquisition of Marley Drug increases patient access to medications, including Medicure's primary care drug, ZYPITAMAG® (Pitavastatin) tablets. At Medicure, our passion drives us to innovate and find solutions to better support patients. For more information, please see our website at www.medicure.com and follow us on Twitter at @MedicureInc. For guidelines on engaging with Medicure on social media, please visit bit.ly/MedicureSocial